15 In the SURPASS-1 study, tirzepatide monotherapy at increasing doses of 5, 10, and 15 mg resulted in significant weight loss of 7, 7.8, and 9.5 kg, respectively, at week 40 in patients with T2DM, compared with a 0.7 kg decrease with placebo
Only for Licensed Professionals David Fuller Last Updated On: July 22, 2025 As the demand for injectable fat-dissolving treatments continues to rise, solutions like deoxycholic acid injections (like the FDA-approved Kybella ) have become popular choices for addressing stubborn pockets of fat, especially under the chin
Abhishek, this is an important distinction
GLP-1 as a trend has grown by 1054% in social discussion over the past year, according to Tastewise, a GenAI-powered consumer data platform (see graph below)
Consumer demand can accelerate production or shipment priorities